Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376
- Written by PR Newswire
![]() |
SHANG HAI, March 2, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that it has entered into an exclusive Out-License Agreement (the "Agreement" hereafter) with Shanghai Allist Pharmaceuticals Co., Ltd., ("Allist" hereafter) for the further development, manufacture, use, and sales of...
Read more: Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376















